Oncology Rehabilitation Therapists play a vital role in supporting cancer patients through recovery, helping them regain physical function and improve their quality of life. They address the various side effects of cancer treatments, such as pain, fatigue, limited mobility, and muscle weakness, through personalized rehabilitation programs. These programs often include physical therapy to enhance strength, flexibility, and coordination, as well as occupational therapy to assist patients in performing daily activities. Oncology rehabilitation therapists aim to minimize the impact of cancer treatment on a patient’s ability to function independently, promoting better overall recovery.
Oncology rehabilitation therapists also focus on emotional and psychological well-being, helping patients cope with the mental challenges of cancer treatment. Through counseling, stress management techniques, and emotional support, these specialists assist patients in managing anxiety, depression, and other emotional burdens that may arise. Their holistic approach ensures that patients recover not only physically but also mentally, contributing to a more comprehensive and sustainable recovery process. Oncology rehabilitation therapists play an essential role in enhancing the overall quality of life for cancer patients and survivors. They also collaborate with oncologists, nurses, and other healthcare providers to ensure a coordinated approach to patient care. By promoting functional independence and addressing the whole person, oncology rehabilitation therapists help improve long-term outcomes for cancer survivors.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China